NEW YORK (GenomeWeb News) – Odense, Denmark-based PentaBase has received DKK 2 million (US$339,000) from an unnamed angel investor, the firm said this week.
PentaBase, which is developing molecular diagnostics and sells real-time PCR-based probes, said that the funding will be used to increase sales of its platform technologies, services, and diagnostic tests for infectious diseases. The firm also offers DNA sequencing services.
PentaBase said that the funding came from an anonymous Danish business investor, “who previously [had] experienced similar challenges to those that PentaBase currently have.”
“This funding will primarily be used to increase our sales activities of existing products and the development and protection of our patent portfolio,” PentaBase Founder and CEO Ulf Bech Christensen said in a statement.
Pentabase was founded in 2006 and is developing diagnostic tools for influenza, avian flu, and cancer-related diseases.